📰 Arix Bioscience News
Page 10 - Arix Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Arix Bioscience. Real-time updates on events, politics, business and more.
February 14, 2023
Investegate announcements from Arix Bioscience PLC, Portfolio company Disc Medicine announces $62.5 million financing
February 6, 2023
Investegate announcements from Arix Bioscience PLC, Unaudited NAV for January 2023
February 6, 2023
DJ Director/PDMR Shareholding Arix Bioscience PLC (ARIX) Director/PDMR Shareholding 06-Feb-2023 / 17:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is
February 6, 2023
Investegate announcements from Arix Bioscience PLC, Director/PDMR Shareholding
January 26, 2023
DJ Board Change Arix Bioscience PLC (ARIX) Board Change 26-Jan-2023 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the
January 26, 2023
Investegate announcements from Arix Bioscience PLC, Board Change
January 21, 2023
Cancer continues to be a hot area of investment, and it’s the therapeutic focus of several biotech companies that have closed recent rounds of financing. Meanwhile, the investment arm of a big pharmaceutical company has an infusion of new cash to deploy in therapeutic and digital investments.
January 10, 2023
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
January 6, 2023
Portfolio company Twelve Bio to be acquired alongside $85 million financing of Ensoma co-led by Arix to create best-in-class engineered cell therapy platform  London, UK, 5 January 2023 – Arix Bioscience plc (“Arix” or the “Company”) (LSE: ARIX), a global venture capital company fo...